Scientific Sessions 2025  /  Cardiometabolic Interventions for the Vulnerable Plaque and Vulnerable Patient  /  Opportunities to Implement Cardiometabolic Health Promotion in the Cardiac Cath Lab
Logo

American Heart Association

  35
  0

Final ID:

Opportunities to Implement Cardiometabolic Health Promotion in the Cardiac Cath Lab

  • Michos, Erin  ( Johns Hopkins , Baltimore , Maryland , United States )
  • Shapiro, Michael  ( Wake Forest Univ School of Medicine , Winston Salem , North Carolina , United States )
    • Author Disclosures:
    Erin Michos: DO have relevant financial relationships ; Consultant:Arrowhead:Active (exists now) ; Consultant:Zoll:Past (completed) ; Consultant:Pfizer:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Esperion:Past (completed) ; Consultant:Amgen:Past (completed) ; Consultant:Novartis:Past (completed) ; Consultant:Edwards Lifescience:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Ionis:Active (exists now) | Michael Shapiro: DO have relevant financial relationships ; Consultant:Ionis:Past (completed) ; Consultant:Arrowhead:Past (completed) ; Consultant:Regeneron:Past (completed) ; Researcher:New Amsterdam:Active (exists now) ; Researcher:Merck:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Esperion:Active (exists now) ; Researcher:Cleerly:Active (exists now) ; Researcher:Amgen:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Tourmaline:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:New Amsterdam:Past (completed) ; Consultant:Novartis:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic Interventions for the Vulnerable Plaque and Vulnerable Patient

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Implications of GLP1 Agonism for Atherosclerosis Disease Progression

Lincoff Abraham, Packer Milton

Emerging Horizons of Cardiometabolic Intervention for Coronary Atherosclerosis

Bhatt Deepak, Badimon Juan

More abstracts from these authors:
The Evolution from Statins to Monoclonal Antibodies and Antisense Technology for Lipid Lowering

Michos Erin, Crooke Rosanne, Shapiro Michael

Discussant: PALISADE

Shapiro Michael

You have to be authorized to contact abstract author. Please, Login
Not Available